- SEK28.53bn
- SEK40.60bn
- €1.75bn
- 77
- 15
- 96
- 70
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 41.38 | ||
| PEG Ratio (f) | 0.85 | ||
| EPS Growth (f) | 93.9% | ||
| Dividend Yield (f) | 0.78% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.07 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 21.91 | ||
| Price to Sales | 1.33 | ||
| EV to EBITDA | 13.4 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.17% | ||
| Return on Equity | 4.69% | ||
| Operating Margin | 4.07% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 844.4 | 997.8 | 1,377.4 | 1,510.2 | 1,746.4 | 2,055 | 2,369.25 | 21.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +5.58 | +29.27 | +189.1 | -80.24 | -45.33 | +220.47 | +80.39 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The Company offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The Company focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Directors
- Fredrik Stenmo CHM (50)
- Fredrik Ragmark CEO (56)
- Joe Ryan CFO (54)
- Jaroslaw Urbanczyk CIO (50)
- Andrew Vallance-Owen CMO (68)
- Jenny Brandt GCN (45)
- John Stubbington OTH (53)
- Benedikt von Braunmuehl OTH (51)
- Peder af Jochnick DRC (48)
- Robert af Jochnick DRC (81)
- Arno Bohn IND (72)
- Sonali Chandmal IND (53)
- Michael Flemming IND (63)
- Margareta Nordenvall IND (65)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- August 26th, 2016
- Public Since
- May 23rd, 2017
- No. of Shareholders
- 5,512
- No. of Employees
- 45,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm- Shares in Issue
- 150,138,919
- Address
- Riddargatan 12 A 3Tr, STOCKHOLM, 114 35
- Web
- https://www.medicover.com/
- Phone
- +46 840017600
- Contact
- Hanna Bjellquist
- Auditors
- BDO Sweden AB
Upcoming Events for MCOV B
Q4 2024 Medicover AB Earnings Release
Similar to MCOV B
Ambea AB (publ)
OMX Nordic Exchange Stockholm
Attendo AB (publ)
OMX Nordic Exchange Stockholm
Bonzun AB (publ )
OMX Nordic Exchange Stockholm
Humana AB
OMX Nordic Exchange Stockholm
Medhelp Care AB (publ)
OMX Nordic Exchange Stockholm
FAQ
What is the Medicover AB share price?
As of Today at 21:59 UTC, shares in Medicover AB are trading at SEK190.00. This share price information is delayed by 15 minutes.
How has the Medicover AB share price performed this year?
Shares in Medicover AB last closed at SEK190.00 and the price had moved by +35.81% over the past 365 days. In terms of relative price strength the Medicover AB share price has outperformed the FTSE Global All Cap Index by +16.5% over the past year.
What are the analyst and broker recommendations for Medicover AB?
The overall consensus recommendation for Medicover AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Medicover AB dividend yield?
The Medicover AB dividend yield is 0.71% based on the trailing twelve month period.
Does Medicover AB pay a dividend?
Last year, Medicover AB paid a total dividend of €0.12, and it currently has a trailing dividend yield of 0.71%. We do not have any data on when Medicover AB is to next pay dividends.
When does Medicover AB next pay dividends?
We do not have data on when Medicover AB is to next pay dividends. The historic dividend yield on Medicover AB shares is currently 0.71%.
How do I buy Medicover AB shares?
To buy shares in Medicover AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medicover AB?
As of the previous close price of SEK190.00, shares in Medicover AB had a market capitalisation of SEK28.53bn.
Where are Medicover AB shares listed?
Here are the trading details for Medicover AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: MCOV B
What kind of share is Medicover AB?
Based on an overall assessment of its quality, value and momentum Medicover AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medicover AB share price forecast for 2024?
The analyst consensus target price for shares in Medicover AB is SEK216.22. That is 13.8% above the last closing price of SEK190.00.
Analysts covering Medicover AB currently have a consensus Earnings Per Share (EPS) forecast of €0.26 for the next financial year.
Find out moreWhat is the trend in the Medicover AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medicover AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +33.36%.
As of the last closing price of SEK190.00, shares in Medicover AB were trading +11.38% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medicover AB PE Ratio?
The Medicover AB PE ratio based on its reported earnings over the past 12 months is 41.38. The shares last closed at SEK190.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medicover AB?
Medicover AB's management team is headed by:
- Fredrik Stenmo - CHM
- Fredrik Ragmark - CEO
- Joe Ryan - CFO
- Jaroslaw Urbanczyk - CIO
- Andrew Vallance-Owen - CMO
- Jenny Brandt - GCN
- John Stubbington - OTH
- Benedikt von Braunmuehl - OTH
- Peder af Jochnick - DRC
- Robert af Jochnick - DRC
- Arno Bohn - IND
- Sonali Chandmal - IND
- Michael Flemming - IND
- Margareta Nordenvall - IND